MIS-C is widespread inflammation in the body, and a COVID-19 infection is a high risk factor for developing the condition, according to the CDC.
To investigate a potential link between COVID-19 and MIS-C, researchers at the Memphis, Tenn.-based hospital used samples from about 200 MIS-C patients to find autoantigens associated with the condition, according to a St. Jude news release.
They found “molecular mimicry, where a section of a protein from SARS-CoV-2 closely resembles the human protein SNX8, confusing the immune system and sparking inflammation,” the release said.
This is the first study to discover molecular mimicry as one of the factors for MIS-C, the release said.
Nature published the results Aug. 7.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
